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Abstract: The prevalence of food allergy appears to be steadily increasing in infants and young
children. One of the major challenges of modern clinical nutrition is the implementation of
individualized nutritional recommendations. The management of food allergy (FA) has seen major
changes in recent years. While strict allergen avoidance is still the key treatment principle, it is
increasingly clear that the avoidance diet should be tailored according to the patient FA phenotype.
Furthermore, new insights into the gut microbiome and immune system explain the rising interest in
tolerance induction and immunomodulation by microbiota-targeted dietary intervention. This review
article focuses on the nutritional management of IgE mediated food allergy, mainly focusing on
different aspects of the avoidance diet. A personalized approach to managing the food allergic
individual is becoming more feasible as we are learning more about diagnostic modalities and allergic
phenotypes. However, some unmet needs should be addressed to fully attain this goal.
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1. Introduction
The true prevalence of food allergy is still unclear: a systematic review of challenge proven food
allergy (FA) prevalence in Europe estimates a very low prevalence of FA of 1% [1] compared to single
center studies reporting challenge proven prevalence figures of up to 10%. The latest paper on the
prevalence of food allergies in children in the USA reports the number of reported FA of 7.6% in
children [2] and 10.8% in adults [3].
A small number of foods, such as milk, egg, peanut, tree nuts, wheat, soy, fish, and shellfish,
are responsible of most of IgE mediated allergic reactions [4,5]. These reactions are induced by
allergenic proteins in the foods and are characterized by rapid onset (usually <2 h). These foods can
provoke severe reactions, especially tree nut and peanuts [5,6]. Clinical reactivity to carbohydrates in
mammalian meat is an exception—symptoms can be delayed for as long as 6 h [7].
The cornerstone of the management of FA still relies on avoiding the culprit food, since accidental
ingestion of the offending food may lead to symptoms including serious and potentially life-threatening
reactions, like anaphylaxis [8].
The management of food allergies has seen major transformations in the last decade. It is
increasingly clear that the avoidance diet should be tailored according to the patient FA phenotype [9].
Better characterization of FA phenotypes could help to personalize the dietary management of FA by
the degree of avoidance required.
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Furthermore, there is a greater focus seen on tolerance induction and immunomodulation
by microbiota-targeted dietary intervention to allow for greater control of allergies. In the era of
precision medicine, the field of precision nutrition involves tailored nutritional recommendations to
the individual. To plan personalized nutrition advice for patients with a food allergy, many factors
including clinical history, type of allergen, sensitization profiles, threshold level, dietary habits, food
preferences, physical activity, microbiome and genotype should all be considered.
In the field of food allergy, some of these factors are better-defined thanks to new diagnostic
molecular technologies [10]. Allergen-component resolved diagnostics (CRD) allows differentiating
between a true food allergy from pollen-food syndrome or clinically irrelevant sensitization. CRD
may predict the risk or severity of allergic reactions to specific food by identifying IgE to epitopes
within an allergen source. However, many other components necessary for dietary guidance are poorly
understood and need further investigation to be incorporated into clinical practice.
In this review, we will focus on the nutritional management of IgE mediated food allergy,
the avoidance diet, state of the art tools/therapies, and the remaining knowledge gap.
2. Making an Accurate Diagnosis: The First Step Required to Develop an Avoidance Diet
The first step in the diagnosis of a FA is to distinguish IgE-mediated from non–IgE-mediated
reactions. Most IgE caused reactions occur rapidly (minutes up to 2 h after ingestion) with the rare
exception [11]. Anaphylaxis is the most serious allergic reaction; it is rapid in onset, life-threatening,
and potentially fatal [12]. Different geographical locations show some differences in food allergen
triggers for anaphylaxis. A recent one from Spain suggested milk and eggs allergies are more severe
than nuts in their population [13].
Unlike IgE mediated, non IgE-mediated reactions are typically delayed from hours to weeks after
ingestion of the culprit food(s) [11].
A thourough clinical history is central in diagnosing FA. Components of this history should
ideally include food recalls, as well as timing, characteristics, and severity of symptoms. If the history
suggests an IgE mediated food allergy, skin prick tests (SPT) or food-specific IgE blood tests can be
used to confirm allergy diagnosis [5,14]. A positive test result does not confirm an IgE-mediated
allergic reaction, whereas a negative test, with rare exception, eliminates it [15].
In addition to the SPT and specific IgE tests, oral food challenges (OFC) and CRD are important
tools for allergy diagnosis. OFC remains the gold standard to confirm clinical reactivity, in most
cases [16,17]. Component-resolved diagnostics helps further define specific allergens and reduces
misdiagnosis due to cross-reactivity [18,19]. The usefulness of these tools can be explained through
the classic example—wheat allergy. Wheat allergy is often over diagnosed, due to the low specificity
of wheat IgE testing [20,21]. A patient with a grass pollen allergy may have elevated “wheat IgE
levels” while being wheat tolerant [22]. Therefore, both CRD and OFCs should be implemented in
children with an SPT or IgE positive wheat allergy. CRD increases the accuracy of wheat allergy
diagnosis by identifying the presence of specific IgE to omega-5 gliadin, the antibody highly specific
to wheat allergy [23]. Currently, oral provocation with wheat is the reference test for the diagnosis of
wheat/cereal allergy as it definitely shows if a child will tolerate wheat.
Additionally, profiling the specific IgE repertoire by CRD may help identify falsely diagnosed
allergies in highly polysensitized patients. This can be explained with the case of patients with allergen
extract positive but negative genuine components. In children with multiple sensitization to tree
nuts, including hazelnut, positive IgE extract but negative IgE genuine component are markers of
a probable cross-sensitization with grass pollen. These patients are very likely to be tolerant to hazelnut
in vivo [24]. CRD has become a useful tool for diagnosing FA, though the use of these tests varies
from country to country.; This technique has some limitations that should be considered. For instance,
the allergens are in a recombinant form and not always show the same IgE reactivity that natural
allergens. This is even more relevant in food allergy testing as the allergens used in the reagents
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are processed. Indeed, the oral food challenge (OFC) is the only effective method to confirm the FA
diagnosis, although the other preliminary diagnostic techniques could support the diagnosis.
3. Risk Assessment and Individual Threshold Level
In general, for IgE mediated-food allergy it is very important to identify patients who are likely to
have severe reactions from patients with mild to moderate ones. Unfortunately, as allergy severity
is multifactorial, this is difficult. Possible contributors to severe reactions are allergen bioavailability,
patient habits (e.g., Exercise [25]), and history of anaphylaxis—although many people who have
a history of only mild symptoms can develop anaphylaxis. Allergen-specific IgE levels and CRD may
assist in risk assessment as sensitization to some allergenic molecules is more likely to be related to
systemic rather than local reactions.
For instance, high levels of casein IgE has been shown to correlate with severe reactions, due to
accidental exposure, in cow’s milk allergic children [26]. Similarly, an association between specific IgE
to omega-5 gliadin component and severity of reactions during wheat challenge has been reported [21,
27]. In peanut allergic children, Eller and Bindslev–Jensen documented that symptom severity elicited
during challenge correlated significantly with the levels of Ara h 2 (r(s) 14 0.60, P < 0.0001) [28]. However,
patients with very low or undetectable sIgE may still experience severe allergic reactions [25,29].
The OFC allows us to ascertain information about individual threshold level can guide the
necessary level of food avoidance.
For instance, the challenge food for baked milk contains 1.3 g CM protein (equivalent to 40 mL
CM), and children who react during their CM OFC should avoid it completely due to their severe
phenotype [30].
Lieberman et al. showed that 66% of the patients with egg allergy undergoing baked egg OFC
tolerated baked egg and that most of the reactions were mild and treated with antihistamine alone,
regardless of sIgE and/or SPT. [31].
In our opinion, performing OFC with baked milk or egg in a controlled-setting has the potential
to greatly improve children’s quality of life [32].
4. Avoidance Diet: Towards Personalized Nutrition Advice
Managing food allergies and avoiding food allergic reactions involves an individualized approach
to food allergen avoidance while providing sufficient nutrition [33].
An avoidance diet is a complex undertaking that requires education about label reading, cooking,
preventing cross-contamination, and communicating information to family, caregivers, friends,
and restaurant personnel [34,35]. See Table 1
Table 1. Nutritional management according to risk assessment: What are the challenges?
Challenges of the Nutritional Management According to Risk Assessment
- local availability of food
- lack of understanding about foods to be avoided
- unexpected allergens in foods
- prepacked foods with inadequate allergen labeling
- defining “baked” milk and egg
- identify the “eliciting dose”
- risks of over restrictive diet
- potential long-term effects on health and quality of life
The standard information that should be provided to all patients includes advice on food labels
and relevant labeling laws, hidden allergens, and suitable replacement foods [36]. However, avoidance
advice should be individualized considering individual tolerances, cross-reactivity, and specific
allergens that drive the reaction. Allergies to novel allergens such as alpha-gal will also require
individualized avoidance advice.
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Individualized Allergen Avoidance
4.0.1. Milk and Egg
It is known that a large proportion of children with cow’s milk and egg allergies will be tolerant
to baked milk and egg irrespective of the age or population studied [37]. Baked milk or egg-containing
foods typically refer to muffins, but other forms such as cookies, waffles, and pancakes have also
been suggested. Baked cheese (pizza) has also been suggested for baked milk challenges [38–43].
No established guidelines to determine when to challenge have been established, so testing depends
on combination of history, sIgE, and skin test results. There is limited consensus about the exact time
and temperature of baking/cooking that is required, the need for a wheat/starch matrix, and where the
challenge/food reintroduction should be conducted, e.g., hospital/in-office vs. at home [44–46]. It is,
however, important to realize that some children who react to baked milk or baked egg may experience
severe symptoms, requiring epinephrine. [31,32,46]. Risk factors for severe reactions to baked foods
need further clarification but may include asthma requiring preventative treatment, multiple IgE
mediated food allergies, and a history of anaphylaxis. [45,47]. Baked milk and egg-containing foods
are successfully introduced at home in most children’s diets post a negative challenge with good
compliance; positively affecting the child’s food and texture repertoire [48]. However, as it is unclear if
continued and regular consumption of baked milk and egg-containing foods will speed up tolerance
to uncooked milk or egg [49,50], families should not be pressured about frequent intake unnecessarily.
4.0.2. Peanut, Tree Nuts, Seeds
Previously, patients with peanut or tree nut allergies were advised to avoid all nuts, due to the
risk of cross-reactivity or possible cross-contact/contamination. However, recent studies indicate
that clinical cross-reactivity may be as low as 30% [51]. For instance, walnuts and pecans are highly
cross-reactive with each other, but not with peanuts, hazelnuts or almonds Sensitization or clinical
allergy may develop after a period of unnecessarily exclusion [52]. The British Society for Allergy
and Clinical Immunology (BSACI) guidelines were the first food allergy management guidelines
to recommend active inclusion of tolerated nuts in diets of individuals with peanut or tree nut
allergy [53,54]. Peanuts are legumes, but allergy to other legumes is generally uncommon among
those with peanut allergy, though this does depend on geography and local diet [55,56]. Lupine, pea,
and soybean show some apparent cross-reactivity for patients who are highly allergic to peanut,
although it is very difficult to separate cross-reactivity from de novo sensitization. The risk of
cross-reaction may be higher for lupin than for other beans, particularly in Europe [57–59]. In the case
of lupine allergy, patients need to be informed about foods containing lupin which may include pies,
certain breads, and pastries.
Seeds are being used more often in commercial and gourmet foods—most commonly flaxseed,
sesame, sunflower, poppy, pumpkin, and mustard seeds [60]. Sesame and mustard seeds are among
the 14 most prevalent allergens in the EU, but not in the US [61]. In Europe, prevalence data
indicates sesame and mustard seed allergies are geographically disproportionate: high in some
areas (France and Spain), much lower in others (Germany and the Nordic countries) and unknown in
Eastern Europe [62]. Mustard and sesame seeds are often hidden in commercial foods, making
scrutiny of labels required at all times. Sesame seed allergy is not commonly seen outside of
Israel and Europe [63]. In addition to scrutiny of labels, children with sesame allergy should always
avoid sesame oil as it is cold/expeller pressed [64].
4.0.3. Fruit and Vegetable Allergies
Allergies to fruit and vegetables, in particular, require individualized advice as symptoms range
from milder symptoms triggered by pollen-food syndrome (PFS, secondary IgE mediated food allergy)
to more severe symptoms triggered by lipid transfer protein syndrome (LTP, primary IgE mediated
food allergy) [65]. It is important to differentiate between these two presentations of fruit and vegetable
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allergies as that will direct the dietary advice given. With PFS, cooked, canned, baked, microwaved
fruit and vegetables are allowed, whereas fruit/vegetable should be completely avoided in the case of
LTP allergies. The degree to which cross-reactive fruit and vegetables (including soy and nuts) should
be avoided requires careful diagnostic evaluation as blanket avoidance advice is not advocated [66–68].
4.0.4. Fish and Shellfish Allergy
It is important to distinguish between fish and shellfish (crustacean and mollusks) allergies. Fish
and shellfish allergies may co-exist [69] but the main allergens differ, and cross-reactivity between
fish and shellfish is unlikely. The main allergen in fish is β parvalbumin; in the case of shellfish,
the major allergen is tropomyosin [70]. Additionally, allergy to a certain fish or shellfish does not imply
allergies to all species in that particular group [71,72]. Subjects who suffer from fish allergy have only
about a 50% probability of being cross-reactive to another fish species. This is significantly lower than
those with shellfish allergies, who have up to a 75% chance of cross-reactivity [15]. In addition
to the allergens derived from fish themselves, fish contaminants, such as the parasite Anisakis,
can also cause allergic reactions, meaning Anisakis allergy can be falsely diagnosed as a fish allergy.
In particular, Anisakis allergy correlated to prevalence of parasitic infection in fish—for example,
in Spain and Southern Italy, there is a higher prevalence of Anisakis allergy due to moderately frequent
Anisakis infection. These allergic patients develop IgE against tropomyosin from Anisakis. As always,
sensitization depends in part on the consumption pattern of fish (cooked, undercooked or raw) and
the infection pattern of fish in the local region [73].
4.0.5. Alpha-Galactosidase
Alpha galactosidase (Alpha-gal) allergy is characterized by delayed (4 to 6 h after the ingestion)
hypersensitivity reactions to mammalian meats and is mediated by IgE antibodies to the oligosaccharide
galactose-alpha 1,3-galactose. It requires avoidance of mammalian meats and their organ meat. Some
individuals also need to avoid ice-cream, milk, and milk products but the degree of avoidance and foods
being avoided should be discussed with the allergist. This decision can be made based on past history of
reactions or tolerance [74,75]. Where the history is unclear, or the food has not been eaten in the past, an oral
food challenge can be conducted [76].
5. Nutritional Impact of Food Allergies: Growth and Nutrient Intake
There is rising concern that children with FA have an insufficient nutrient intake or nutrient
imbalance leading to adverse health implications. Data published over the past few years indicates
that children with food allergies (IgE, non-IgE, and mixed presentations of IgE and non-IgE)
show growth impairment, both in weight and length. They are often underweight [77], and in
the case of chronic malnutrition, they become stunted, e.g., a child who is too short for his/her
age [78,79]. However, excessive weight gain has also been reported in children with food allergies,
but poorly researched [77,80,81]. A recent international survey conducted by Meyer et al. [82] included
430 patients from twelve allergy centers world-wide. The pooled data indicated that 6% were
underweight, 9% stunted, 5% undernourished, and 3–5% were overweight. In this study, growth
impairments varied by allergy profile. Children with cow’s milk allergy (CMA) had a lower weight
for age z-score, as a result of acute malnutrition or “wasting”; children with mixed IgE and non-IgE
mediated FA were stunted, and children with only non-IgE FA were underweight with lower body
mass index (BMI). Very different growth patterns were observed between children from different
countries. Atopic comorbidities did not affect growth.
Avoidance diets required for FA management place children at risk for potential inadequate
nutrition. In this regard, a number of studies have investigated the nutritional adequacy of elimination
diets. However, most of them have been conducted in young children aged six months to four years.
Children with food allergies (IgE, non-IgE, and mixed presentations of IgE and non-IgE) are also at
higher risk of insufficient intake of protein, calories, vitamins, and minerals [83–87]. The micronutrients
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implicated are iodine, calcium, and vitamin D, especially in children with CMA [83,88,89]. However,
it has been shown that children with cow’s milk allergies or multiple food allergies are able to
achieve similar mean intakes of nutrients as healthy children when receiving nutrition counselling and
substitution of nutritionally equivalent foods [78,83,90–92].
Limited data exist on dietary intake in teenagers and adults with food allergies, with contrasting
results [93,94]. One study reports, higher intakes of calcium, iron, folate, and vitamin E have been
demonstrated in participants >20 years with food allergy [44]. Conversely, lower intakes of calcium
and phosphorous have been reported in young adults with CMA, with one study reporting that 27%
were at risk of osteoporosis [48]. Maslin et al. showed no significant difference between these two
groups and control groups with the intake of calcium. Iron, copper, zinc, selenium, and iodine were
below the Recommended National Intakes (RNI) for both groups and their controls [94]. There are
currently no data on BMI status on adults with IgE mediated food allergy. These factors need to be
considered when providing nutrition advice to children and adults with food allergies. Although
information on healthy eating is important, consideration to vitamin and mineral supplementation in
hypoallergenic formulas in the case of children should be given [84,95]. Nutritional counselling and
monitoring growth and development are crucial in the management of FA, as the avoidance diet may
affect the well-being of FA patients (see Table 2).
Table 2. Effect of avoidance diet on patients.
Effect of Avoidance Diet
- poor growth
- micronutrient deficiencies
- altered taste perception
- long term effects on food preferences and choices
- reduced quality of life
6. Food Behaviour and Preferences
In children with FA, the development of their food habits and preferences takes place in the context
of their chronic condition. Since parents have the main responsibility for the dietary management of
their child’s food allergies [96], their parenting style and the way they interact with the child during
feedings both have an effect on a child’s food habits [97]. A child’s food allergies add a burden to
parents [98]. Food refusal has also been shown to occur in toddlers with food allergies [99] and more
specifically eosinophilic gastrointestinal disease [100]. Additionally, a study on children aged 5 to
14 years in France showed that children who have outgrown their food allergies are more reluctant to
try new foods than their siblings [101]. Food neophobia and refusal could result from unnecessarily
high dietary restrictions that parents place on their children due to increased anxiety and fear of an
allergic reaction [102]. The long-term effects of avoidance diet on food behavior and preferences needs
further investigation.
Food choice behavioral problems have been documented in older children or adults with food
allergies. Teenagers with food allergies, strive to eat the same foods as their peers, often leading to
risk taking behavior. However, they reported reluctance to try new foods when away from home.
In contrast to the non-food allergic teens, those with food allergies felt that parental control over food
intake was to protect them [103].
Adults with FA felt that their allergies limited them from the pleasure of eating and they often
found it difficult to find safe foods. They also felt that the need to be constantly organized to have safe
foods available was a burden [104].
7. Microbiota-Diet and Genetic Factors: A Complex and Still Unknown Interplay
FA is thought to be the result of a disruption of mucosal immunological tolerance, due to dietary
factors, gut microbiota, and interactions between them [105]. Different bacterial taxa may be associated
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with different food allergy subphenotyes. Differences in gut microbiome have been observed in subjects
with tree-nut allergy in respect to those with cow’s milk allergy [106,107]. The observed differences
may however be influenced by age, population, sex and diet. Furthermore, recent data indicate that
for cow’s milk allergy, the microbiome differs between those children who are sensitized vs. not
sensitized [108], those with clinical allergy vs. those with no allergy [109], and those who develop
tolerance vs. those who do not [110]. Overall, these findings suggest the possibility to manipulate the
gut microbiota with preventive or therapeutic purposes.
Data in pediatric studies indicate that certain pre and probiotics tested may address dysbiosis [111]
and may even induce tolerance development [112]. More clinical trials regarding the use of pre and
probiotics in the management of food allergies are needed before clinical recommendations can be made.
These studies should also consider genetic background and age in their design. Another important
issue to be considered is that the gut microbiome composition and diversity can be modulated by host
genetic profiling [113]. A host’s genetic composition is able to modulate their gut microbiota, which is
another paramount area of study [114].
Whether diet diversity may improve dysbiosis and microbial diversity in those with food allergies
remains to be seen [115].
Further studies need to investigate the complex interplay between the host genetic components
and environmental factors, including the microbiota and diet, in the pathogenesis and expression of
food allergy that is still largely unknown.
8. The Technology Revolution in FA Management
Increasingly, personalized devices to aid in allergen detection have been invented, and the industry
has grown rapidly over the last decade [116]. These technologies have resulted both from increased
demand for transparency of product information and scientific advancements. [117]. The rapid drop
in the price of personalised nutrition devices has resulted in mass accessibility [118]. Deciphering food
labels is a difficult task and for those with allergies, a daily chore that if done incorrectly, can lead to
negative and possibly fatal outcomes [119,120].
New digital technologies have started to appear on the market that attempts to address the
daily challenges families face when choosing products for a child with allergies. For a full review
of technologies involved in portable allergy products, we refer readers to the comprehensive article
by Ross, G.M.S [121]. There have been a number of technology services advising about potential
risks related to food composition. For concerned consumers, having instant access to information can
remove the guesswork and can potentially save time. However, there are no validated, personalized
systems for testing individual meals for specific food source products. It is also noteworthy that
sometimes component recipes change and accuracy as well of lack of clinical validation of these
products are issues frequently raised.
With such rapid advances in the scientific and technology industry, it is, however, important
to have comprehensive communication between consumer advocates, the food industry, and the
clinicians to help improve avoidance of allergens by technical fixes, while being fully aware of the
limitations and current lack of validation of these products in a variety of matrices or in foods with
multiple ingredients (see Figure 1). What is clear, is that management of allergies will require the
intervention of a specialist multidisciplinary team with registered dietitians playing a key role in
supporting families while staying abreast of new technologies [122].
Some examples of products currently available on the market, outlining their pros, cons and
future considerations, are listed below (Table 3).
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Table 3. Personalized nutrition offering for Food allergies.
Currently Available
Resources or Tools Description Pros Cons Future directions
Apps
SmartwithfoodTM, SpoonguruTM,
FoodmaestroTM, WhiskTM. These apps
are available free to consumers. Through
barcode scanning, image recognition,
natural language processing and
machine learning technology, consumers
can obtain instant information whether a
product contains allergens.
• These app scanners provide quick
results that are easy to understand
and can always be on hand.
• They can provide peace of mind as a
second line.
• The platforms rely on food
manufacturers to provide accurate
product information in terms of
their recipes.
• The app only reports on a limited number
of allergens.
• The app is not a medical device and,
therefore, cannot replace a medical
professional’s advice; consumers should
always ask questions and always check
the food label.
• Apps should increase the number of
allergens they have
information about.
• New products could ideally be
developed based on the popularity
of scanned products.
Food scanners
Scanners such as TellspecTM, ScioscanTM
and NimaTM are handheld, mobile
devices that use hyperspectral or imaging
technology to analyse nutritional
information and detect allergens.
• These scanners are small, provide
quick results that are easy
to understand.
• They can provide peace of mind as a
second line.
• These products may provide some
reassurance once standard allergen
avoidance advice has been followed
but should NOT be used instead of
advice provided by the allergist
or dietitian.
• Costs can be prohibitive.
• It is not a medical device and, therefore,
consultation with a healthcare
professional is still required.
• Concerns have been raised about the
accuracy in detecting allergens (Popping
et al., 2017).
• Scanners work best with homogenous
solid products. For example, testing may
be highly inaccurate in foods with
multiple ingredients or high-fat matrices.
• It is not clear who holds the data on
these products.
• These tools need to be
clinically validated
• These tools need to comply with
medical devices regulation
Wearable devices
Such as Allergy AmuletTM is a device
that is worn as a necklace and works by
inserting strips into food, available
in 2019.
• A mobile and attractive device that
provides instant results.
• These products may provide some
reassurance once standard allergen
avoidance advice has been followed.
• It is not a medical device
• It is important the consumers read labels
and ask about ingredients to the dietitian.
• Have not been validated for accuracy
• Needs to be clinically validated.
• In the future, potentially sensors or
implants could detect from a
nanoparticle of food.
CRISPR
Is the new technology which enables
DNA of food (and humans) to be edited.
This means that new foods and products
can be developed where the culprit
allergen’s DNA has been edited without
the devastating effects.
Consumers with allergies will have a wider
variety of foods to eat
• Technology is still expensive.
• Some allergens can be removed.
• It is not clear how differentiating
appropriately altered foods from native
food sources. For some allergenic sources,
such as wheat, the genetic complexity of
the crop is unlikely to allow simple
genetic knockout of allergenic genes.
• Current lack of understanding of
the long-term impact of eating
gene-edited foods.
• Extensive public education will
be required.
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Figure 1. Nutrition approach: unmet needs.
9. Conclusions
A personalized approach to managing the food allergic individual is becoming more feasible
as we are learning more about diagnostic modalities and allergic phenotypes. The availability
of specialized foods and technology are increasing which also enables the clinicians to provide
personalized advice. A multidisciplinary team approach, including a dietitian, is crucial to provide
individualized recommendations to patients.
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